Anpario plc (AIM:ANP)

Market Cap	97.83M
Revenue (ttm)	43.93M
Net Income (ttm)	5.15M
Shares Out	20.60M
EPS (ttm)	0.30
PE Ratio	15.98
Forward PE	14.34
Dividend	0.12 (2.44%)
Ex-Dividend Date	Nov 13, 2025

Volume	14,397
Average Volume	17,347
Open	472.55
Previous Close	475.00
Day's Range	471.00 - 478.75
52-Week Range	286.00 - 536.50
Beta	0.88
RSI	34.58
Earnings Date	Dec 12, 2025

About Anpario

Anpario plc, together with its subsidiaries, manufactures and distributes natural animal feed additives for animal health, nutrition, and biosecurity. Its health and performance category offers various products that support and maintain animal gut health, including phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; and feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzy...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1996
• Employees: 157
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: ANP

Financial Performance

In 2024, Anpario's revenue was 38.20 million, an increase of 23.22% compared to the previous year's 31.00 million. Earnings were 4.11 million, an increase of 62.66%.